{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:52:57Z","timestamp":1785883977274,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["R120442"],"award-info":[{"award-number":["R120442"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R02118X\/1 ; MC_PC_21034"],"award-info":[{"award-number":["MR\/R02118X\/1 ; MC_PC_21034"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR134531"],"award-info":[{"award-number":["NIHR134531"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224263\/Z\/21\/Z"],"award-info":[{"award-number":["224263\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vaccine immunogenicity varies across populations, yet drivers remain unclear. We compared systemic (plasma) and mucosal (coprological) antibody responses to the oral typhoid vaccine Ty21a, quantified by ELISA, among Ugandan adolescents from urban and\n                    <jats:italic>Schistosoma mansoni<\/jats:italic>\n                    -endemic rural settings. Urban participants elicited higher responses. Causal mediation analysis indicated that\n                    <jats:italic>S. mansoni<\/jats:italic>\n                    partly accounted for reduced mucosal, but not systemic, responses in rural participants, highlighting implications for oral vaccine effectiveness in endemic settings.\n                  <\/jats:p>","DOI":"10.1038\/s41541-026-01484-y","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:44:30Z","timestamp":1778917470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rural-urban differences in oral typhoid vaccine responses in Uganda: contribution of Schistosoma mansoni"],"prefix":"10.1038","volume":"11","author":[{"given":"Bridgious","family":"Walusimbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Natukunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Amongin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Heyraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Baine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacent","family":"Nassuuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyaviira","family":"Nkurunungi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"1484_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4161\/hv.6.7.11278","volume":"6","author":"V Jiang","year":"2010","unstructured":"Jiang, V., Jiang, B., Tate, J., Parashar, U. D. & Patel, M. M. Performance of rotavirus vaccines in developed and developing countries. Hum. Vaccines 6, 532\u2013542 (2010).","journal-title":"Hum. Vaccines"},{"key":"1484_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0264-410X(02)00348-1","volume":"21","author":"H Hallander","year":"2002","unstructured":"Hallander, H. et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 21, 138\u2013145 (2002).","journal-title":"Vaccine"},{"key":"1484_CR3","doi-asserted-by":"publisher","first-page":"e1860","DOI":"10.1016\/S2214-109X(24)00340-1","volume":"12","author":"A Natukunda","year":"2024","unstructured":"Natukunda, A. et al. Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials. Lancet Glob. Health 12, e1860\u2013e1870 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1484_CR4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1093\/infdis\/jiw066","volume":"213","author":"CE Clark","year":"2016","unstructured":"Clark, C. E. et al. Maternal helminth infection is associated with higher infant immunoglobulin A titers to antigen in orally administered vaccines. J. Infect. Dis. 213, 1996\u20132004 (2016).","journal-title":"J. Infect. Dis."},{"key":"1484_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12939","volume":"44","author":"A Natukunda","year":"2022","unstructured":"Natukunda, A. et al. The effect of helminth infection on vaccine responses in humans and animal models: a systematic review and meta-analysis. Parasite Immunol. 44, e12939 (2022).","journal-title":"Parasite Immunol."},{"key":"1484_CR6","doi-asserted-by":"publisher","first-page":"e040426","DOI":"10.1136\/bmjopen-2020-040426","volume":"11","author":"G Nkurunungi","year":"2021","unstructured":"Nkurunungi, G. et al. Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the \u2018POPulation differences in VACcine responses\u2019(POPVAC) programme. BMJ Open 11, e040426 (2021).","journal-title":"BMJ Open"},{"key":"1484_CR7","doi-asserted-by":"publisher","first-page":"e040430","DOI":"10.1136\/bmjopen-2020-040430","volume":"11","author":"L Zirimenya","year":"2020","unstructured":"Zirimenya, L. et al. Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the \u2018POPulation differences in VACcine responses\u2019(POPVAC) programme. BMJ Open 11, e040430 (2020).","journal-title":"BMJ Open"},{"key":"1484_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1460183","volume":"15","author":"A Natukunda","year":"2024","unstructured":"Natukunda, A. et al. Pre-vaccination Schistosoma mansoni and hookworm infections are associated with altered vaccine immune responses: a longitudinal analysis among adolescents living in helminth-endemic islands of Lake Victoria, Uganda. Front. Immunol. 15, 1460183 (2024).","journal-title":"Front. Immunol."},{"key":"1484_CR9","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.3389\/fimmu.2019.02582","volume":"10","author":"LC Dahora","year":"2019","unstructured":"Dahora, L. C. et al. IgA and IgG1 Specific to Vi polysaccharide of Salmonella typhi correlate with protection status in a typhoid fever controlled human infection model. Front. Immunol. 10, 2582 (2019).","journal-title":"Front. Immunol."},{"key":"1484_CR10","doi-asserted-by":"publisher","first-page":"e1826","DOI":"10.1016\/S2214-109X(24)00280-8","volume":"12","author":"G Nkurunungi","year":"2024","unstructured":"Nkurunungi, G. et al. The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial. Lancet Glob. Health 12, e1826\u2013e1837 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1484_CR11","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/cid\/ciy761","volume":"68","author":"RE Sanya","year":"2019","unstructured":"Sanya, R. E. et al. The Impact of intensive versus standard anthelminthic treatment on allergy-related outcomes, Helminth infection intensity, and Helminth-related morbidity in lake Victoria Fishing Communities, Uganda: results from the LaVIISWA cluster-randomized trial. Clin. Infect. Dis. 68, 1665\u20131674 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"1484_CR12","doi-asserted-by":"publisher","first-page":"e1849","DOI":"10.1016\/S2214-109X(24)00282-1","volume":"12","author":"J Nassuuna","year":"2024","unstructured":"Nassuuna, J. et al. The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial. Lancet Glob. Health 12, e1849\u2013e1859 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1484_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/cea.13335","volume":"49","author":"G Nkurunungi","year":"2019","unstructured":"Nkurunungi, G. et al. Do helminth infections underpin urban-rural differences in risk factors for allergy-related outcomes? Clin. Exp. Allergy 49, 663\u2013676 (2019).","journal-title":"Clin. Exp. Allergy"},{"key":"1484_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/mi.2017.62","volume":"10","author":"NY Lycke","year":"2017","unstructured":"Lycke, N. Y. & Bemark, M. The regulation of gut mucosal IgA B-cell responses: recent developments. Mucosal Immunol. 10, 1361\u20131374 (2017).","journal-title":"Mucosal Immunol."},{"key":"1484_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.chom.2021.02.009","volume":"29","author":"AM Weis","year":"2021","unstructured":"Weis, A. M. & Round, J. L. Microbiota-antibody interactions that regulate gut homeostasis. Cell Host Microbe 29, 334\u2013346 (2021).","journal-title":"Cell Host Microbe"},{"key":"1484_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/infdis\/173.1.269","volume":"173","author":"EA Sabin","year":"1996","unstructured":"Sabin, E. A., Araujo, M. I., Carvalho, E. M. & Pearce, E. J. Impairment of tetanus toxoid-specific Thl-like immune responses in humans infected with Schistosoma mansoni. J. Infect. Dis. 173, 269\u2013272 (1996).","journal-title":"J. Infect. Dis."},{"key":"1484_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu0419","volume":"11","author":"MD Manurung","year":"2025","unstructured":"Manurung, M. D. et al. Systems analysis unravels a common rural-urban gradient in immunological profile, function, and metabolic dependencies. Sci. Adv. 11, eadu0419 (2025).","journal-title":"Sci. Adv."},{"key":"1484_CR18","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","volume":"2","author":"C Naylor","year":"2015","unstructured":"Naylor, C. et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2, 1759\u20131766 (2015).","journal-title":"EBioMedicine"},{"key":"1484_CR19","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.4269\/ajtmh.18-0143","volume":"99","author":"JM Lauer","year":"2018","unstructured":"Lauer, J. M. et al. Unsafe drinking water is associated with environmental enteric dysfunction and poor growth outcomes in young children in rural southwestern Uganda. Am. J. tropical Med. Hyg. 99, 1606 (2018).","journal-title":"Am. J. tropical Med. Hyg."},{"key":"1484_CR20","doi-asserted-by":"publisher","first-page":"e0007875","DOI":"10.1371\/journal.pntd.0007875","volume":"14","author":"L Mbuyi-Kalonji","year":"2020","unstructured":"Mbuyi-Kalonji, L. et al. Non-typhoidal Salmonella intestinal carriage in a Schistosoma mansoni endemic community in a rural area of the Democratic Republic of Congo. PLoS Negl. Trop. Dis. 14, e0007875 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1484_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/iai.44.2.274-281.1984","volume":"44","author":"R Melhem","year":"1984","unstructured":"Melhem, R. & LoVERDE, P. T. Mechanism of interaction of Salmonella and Schistosoma species. Infect. Immun. 44, 274\u2013281 (1984).","journal-title":"Infect. Immun."},{"key":"1484_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01116-x","volume":"10","author":"J Nassuuna","year":"2025","unstructured":"Nassuuna, J. et al. Helminth driven gut inflammation and microbial translocation associate with altered vaccine responses in rural Uganda. npj Vaccines 10, 56 (2025).","journal-title":"npj Vaccines"},{"key":"1484_CR23","doi-asserted-by":"publisher","unstructured":"Floudas, A. et al. Schistosoma mansoni worm infection regulates the intestinal microbiota and susceptibility to colitis. Infect. Immun. https:\/\/doi.org\/10.1128\/IAI.00275-19 (2019).","DOI":"10.1128\/IAI.00275-19"},{"key":"1484_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30412-x","volume":"8","author":"TP Jenkins","year":"2018","unstructured":"Jenkins, T. P. et al. Schistosoma mansoni infection is associated with quantitative and qualitative modifications of the mammalian intestinal microbiota. Sci. Rep. 8, 12072 (2018).","journal-title":"Sci. Rep."},{"key":"1484_CR25","doi-asserted-by":"publisher","unstructured":"Walusimbi, B. et al. The gut microbiome and metabolome associate with Schistosoma mansoni infection and cardiovascular disease risk in Uganda. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-026-68983-3 (2026).","DOI":"10.1038\/s41467-026-68983-3"},{"key":"1484_CR26","doi-asserted-by":"publisher","first-page":"e040425","DOI":"10.1136\/bmjopen-2020-040425","volume":"11","author":"G Nkurunungi","year":"2021","unstructured":"Nkurunungi, G. et al. Population differences in vaccine responses (POPVAC): scientific rationale and cross-cutting analyses for three linked, randomised controlled trials assessing the role, reversibility and mediators of immunomodulation by chronic infections in the tropics. BMJ Open 11, e040425 (2021).","journal-title":"BMJ Open"},{"key":"1484_CR27","doi-asserted-by":"publisher","first-page":"e040426","DOI":"10.1136\/bmjopen-2020-040426","volume":"11","author":"G Nkurunungi","year":"2021","unstructured":"Nkurunungi, G. et al. Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the \u2018POPulation differences in VACcine responses\u2019 (POPVAC) programme. BMJ Open 11, e040426 (2021).","journal-title":"BMJ Open"},{"key":"1484_CR28","doi-asserted-by":"publisher","first-page":"e1838","DOI":"10.1016\/S2214-109X(24)00281-X","volume":"12","author":"L Zirimenya","year":"2024","unstructured":"Zirimenya, L. et al. The effect of intermittent preventive treatment for malaria with dihydroartemisinin\u2013piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial. Lancet Glob. Health 12, e1838\u2013e1848 (2024).","journal-title":"Lancet Glob. Health"},{"key":"1484_CR29","doi-asserted-by":"publisher","first-page":"e040427","DOI":"10.1136\/bmjopen-2020-040427","volume":"11","author":"A Natukunda","year":"2021","unstructured":"Natukunda, A. et al. Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the \u2018POPulation differences in VACcine responses\u2019 (POPVAC) programme. BMJ Open 11, e040427 (2021).","journal-title":"BMJ Open"},{"key":"1484_CR30","doi-asserted-by":"publisher","first-page":"e040430","DOI":"10.1136\/bmjopen-2020-040430","volume":"11","author":"L Zirimenya","year":"2021","unstructured":"Zirimenya, L. et al. Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the \u2018POPulation differences in VACcine responses\u2019 (POPVAC) programme. BMJ Open 11, e040430 (2021).","journal-title":"BMJ Open"},{"key":"1484_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0140-6736(10)61457-2","volume":"377","author":"EL Webb","year":"2011","unstructured":"Webb, E. L. et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant\u2019s response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet 377, 52\u201362 (2011).","journal-title":"Lancet"},{"key":"1484_CR32","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1017\/S0031182014000626","volume":"141","author":"PL Corstjens","year":"2014","unstructured":"Corstjens, P. L. et al. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels. Parasitology 141, 1841\u20131855 (2014).","journal-title":"Parasitology"},{"key":"1484_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4269\/ajtmh.2007.77.685","volume":"77","author":"JJ Verweij","year":"2007","unstructured":"Verweij, J. J. et al. Simultaneous detection and quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am. J. Trop. Med. Hyg. 77, 685\u2013690 (2007).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1484_CR34","first-page":"239","volume":"8","author":"IO Emmanuel","year":"2008","unstructured":"Emmanuel, I. O. & Ekkehard, D. Epidemiology, of bilharzias (schistosomiasis) in Uganda from 1902 until 2005. Afr. Health Sci. 8, 239\u2013243 (2008).","journal-title":"Afr. Health Sci."},{"key":"1484_CR35","doi-asserted-by":"publisher","first-page":"e0008783","DOI":"10.1371\/journal.pntd.0008783","volume":"14","author":"MM Gibani","year":"2020","unstructured":"Gibani, M. M. et al. Homologous and heterologous re-challenge with Salmonella typhi and Salmonella paratyphi A in a randomised controlled human infection model. PLoS Negl. Trop. Dis. 14, e0008783 (2020).","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01484-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01484-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:35:02Z","timestamp":1785882902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01484-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01484-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8832138\/v1","asserted-by":"object"}]},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.N. and A.M.E. report grants from Wellcome Trust. G.N. reports funding from the EDCTP2 programme supported by the European Union. A.M.E. reports funding from Medical Research Council (MRC) of the United Kingdom for conduct of the parent study; A.M.E. reports funding from NIH, Science for Africa Foundation and DELTAS Africa, outside the submitted work. B.W. and A.M.E. report funding from the Royal Society outside the submitted work. A.M.E., B.W. and A.N. report support from UK National Institute of Health and care Research (NIHR). A.M.E. further reports support from the Serum Institute of India, Uganda National Expanded Programme on Immunisation, and Emergent BioSolutions for conduct of the parent study. The other authors do not have a competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"155"}}